GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

blisibimod   Click here for help

GtoPdb Ligand ID: 9518

Synonyms: A-623 | AGP3 peptibody [5] | AMG 623 | Fc-Agp-3 [1]
Immunopharmacology Ligand
Compound class: Peptide
Comment: Blisibimod is a peptibody fusion containing four BAFF binding domains fused to a human Fc domain. By sequestering circulating BAFF ligand, it acts as a functional antagonist of BAFF interaction with the TACI receptor on B cells.
Peptide sequences and structural information for this peptide are available from its IMGT/mAb-DB entry. The peptide sequence for blisibimod is claimed in Amgen's patent WO2002092620 [5].
Classification Click here for help
Compound class Peptide
International Nonproprietary Names Click here for help
INN number INN
9583 blisibimod
Synonyms Click here for help
A-623 | AGP3 peptibody [5] | AMG 623 | Fc-Agp-3 [1]
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 413
Other databases
GtoPdb PubChem SID 336446905
Search PubMed clinical trials blisibimod
Search PubMed titles blisibimod
Search PubMed titles/abstracts blisibimod